Research analysts at StockNews.com began coverage on shares of Stericycle (NASDAQ:SRCL – Get Free Report) in a research report issued to clients and investors on Thursday. The brokerage set a “hold” rating on the business services provider’s stock.
Stericycle Stock Performance
Shares of Stericycle stock opened at $61.98 on Thursday. Stericycle has a one year low of $37.78 and a one year high of $61.99. The company has a market cap of $5.75 billion, a PE ratio of 163.11, a P/E/G ratio of 3.38 and a beta of 1.10. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.13 and a current ratio of 1.20. The business has a 50-day simple moving average of $61.40 and a 200-day simple moving average of $58.58.
Hedge Funds Weigh In On Stericycle
A number of institutional investors and hedge funds have recently made changes to their positions in SRCL. Citigroup Inc. lifted its stake in Stericycle by 1,433.7% during the third quarter. Citigroup Inc. now owns 2,046,496 shares of the business services provider’s stock worth $124,836,000 after purchasing an additional 1,913,065 shares during the last quarter. Barclays PLC lifted its stake in Stericycle by 1,416.4% in the third quarter. Barclays PLC now owns 1,595,177 shares of the business services provider’s stock valued at $97,306,000 after buying an additional 1,489,981 shares during the last quarter. Pentwater Capital Management LP purchased a new stake in Stericycle in the second quarter valued at approximately $83,010,000. Magnetar Financial LLC purchased a new stake in Stericycle in the second quarter valued at approximately $81,596,000. Finally, Millennium Management LLC lifted its stake in Stericycle by 1,057.6% in the second quarter. Millennium Management LLC now owns 1,315,274 shares of the business services provider’s stock valued at $76,457,000 after buying an additional 1,201,653 shares during the last quarter. 98.82% of the stock is owned by institutional investors and hedge funds.
About Stericycle
Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.
See Also
- Five stocks we like better than Stericycle
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What is the S&P/TSX Index?
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Best Stocks Under $5.00
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.